Peter Giunta

Represented Cipla Limited and Cipla USA, Inc.. in a patent infringement lawsuit filed against Sunovion Pharmaceuticals, Inc. involving Sunovion's levalbuterol product. The parties settled before trial.

Represent MSN Laboratories Private Limited and MSN Pharmaceuticals, Inc. in a Hatch-Waxman patent infringement lawsuit filed by Boehringer involving MSN's afatinib product. This case is still pending.

Represented Cipla Limited and Cipla USA, Inc. in a Hatch-Waxman patent infringement lawsuit filed by Amgen involving Cipla's cinacalcet product. Amgen dismissed the action pursuant to a settlement.

Represented Lehigh Valley Technologies, Inc., Endo Global Ventures, Endo Ventures Limited, and Generics Bidco I, LLC in a Lanham Act false advertising lawsuit at the ITC against Virtus Pharmaceuticals, LLC involving Virtus alleged false advertising of its potassium chloride product. The case settled.

Represented Lehigh Valley Technologies, Inc., Endo Global Ventures, Endo Ventures Limited, and Generics Bidco I, LLC in a Lanham Act false advertising lawsuit against Sandoz and Upsher-Smith involving defendants alleged false advertising of its potassium chloride product. The case settled.

Represented Lehigh Valley Technologies, Inc., Endo Global Ventures, Endo Ventures Limited, and Generics Bidco I, LLC in a Lanham Act false advertising lawsuit against Virtus Pharmaceuticals, LLC involving Virtus alleged false advertising of its potassium chloride product. The case settled.

Represented Par Sterile Products, LLC, Par Pharmaceutical, Inc., and Par Pharmaceutical Companies, Inc. in a patent infringement lawsuit filed against Luitpold Pharm., Inc. involving Luitpold's epinephrine product. The case was dismissed.

Represented defendant Par Pharmaceuticals, Inc. in this Hatch-Waxman patent infringement lawsuit filed by Merck Sharp & Dohme Corp. involving Par's posaconazole product.

Represented defendant Par Pharmaceuticals, Inc. and Anchen Pharmaceuticals, Inc. in this Hatch-Waxman patent infringement lawsuit filed by Forest Laboratories, LLC involving Par's generic version of Namenda.

Represented Par Sterile Products, LLC, Par Pharmaceutical, Inc., and Par Pharmaceutical Companies, Inc. in a patent infringement lawsuit filed by Fresenius Kabi involving Par's levothyroxine product.

Represented Par Sterile Products, LLC in a patent infringement lawsuit filed by Novartis Pharmaceuticals Corp. involving Par's launch of a zoledronic acid product. Novartis dismissed the case pursuant to a settlement.

Represented defendant Par Pharmaceuticals, Inc. in this Hatch-Waxman patent infringement lawsuit filed by AstraZeneca, A.B. involving Par's saxagliptin product. AstraZeneca stipulated to the dismissal of all claims.

Represented Par Sterile Products, LLC in a Lanham Act false advertising lawsuit against Fresenius Kabi USA, LLC involving Fresenius's alleged false advertising of its vasopressin product. The case settled.